Gaarnis Pharma Private Limited, a active private limited company, was established on 11 March 2016 in Cochin, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230KL2016PTC040342. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 4 professional, Its leadership includes Amalsabu Gopinathanpillai Kalakal (Director), Preethi Santhamma (Director). Past directors included Gerald Joseph Vyakulasamy, Dhamodharan Vijayavarman. It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 72/1292 A, 72/1292 A2, M.A. Tower Ii Asoka Road Kaloor, Cochin, Kerala, 682017.
U24230KL2016PTC040342
040342
11 March 2016
₹2.50 M
₹1.00 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Gaarnis Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amalsabu Gopinathanpillai Kalakal | Director | 11 Mar 2016 | Current |
| Preethi Santhamma | Director | 01 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2024 | Past |
| Pramod Abcsdd | Additional Director | 01 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gaarnis Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 154.94% increase. The company also saw a substantial improvement in profitability, with a 94.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Gaarnis Pharma had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2016 | Idbi Bank Limited | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Gaarnis Pharma has a workforce of 4 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gaarnis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gaarnis Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gaarnis Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Gaarnis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
The activity Preethi Santhamma was appointed as a Director was appointed as a Director on 01 Mar 2024 & has been associated with this company since 1 year 9 months . was completed.
The activity A charge with Idbi Bank Limited amounted to Rs. 0.50 M with Charge ID 100069935 was registered on 17 Dec 2016. was completed.
Progress on Amalsabu Gopinathanpillai Kalakal was appointed as a Director was appointed as a Director on 11 Mar 2016 & has been associated with this company since 9 years 9 months . was documented.
The activity Gaarnis Pharma Private Limited was registered on 11 Mar 2016 with Roc Ernakulam & aged 9 years 9 months as per MCA records. was completed.
The CIN of Gaarnis Pharma Private Limited is U24230KL2016PTC040342.
Gaarnis Pharma Private Limited is headquartered at 72/1292 A, 72/1292 A2, M.A. Tower Ii Asoka Road Kaloor, Cochin, Kerala, 682017.
Gaarnis Pharma Private Limited was incorporated on 11 March 2016.
The current directors of Gaarnis Pharma Private Limited are
The primary industry of Gaarnis Pharma Private Limited is Trade.
Gaarnis Pharma Private Limited is unlisted.
The authorized capital of Gaarnis Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹1.00 M.
The compliance status of Gaarnis Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX